Treatment of Juvenile Idiopathic Arthritis

излечение ревматоидного артрита

излечение ревматоидного артрита

The following letter was written by the J. family to the iMER company. They contacted us while looking for a solution to the medical challenges faced by their 15 year old daughter who was suffering from J.I.A. – Juvenile Idiopathic Arthritis. JIA is a subset of arthritis seen in childhood, which may be transient and self-limited or chronic. It is an autoimmune disorder.

Treatment was administered in Russia with Sulfasalazin together with Dicofenac followed by Meloxicam – this protocol brought with it terrible complications. The child developed Toxic Epidermal Necrolysis over 70% of her body. She needed resuscitation and was in a life threatening situation.

It was clear to the family that their daughter required immediate and specialized medical attention- Her medical material was reviewed by Dr. Berkune, a Pediatric immunology specialist and they accepted the offer to bring her to the Hadassah Medical Center in Ein Kerem.This is the heartwarming letter they sent us:

“Thank you to the wonderful team at iMER – Luba, Sasha and Leah for the help with the treatment and cure for our daughter. I pray that the treatment and warm concern will come back to you 100 fold.
With great respect and a million thanks,
The J. family 25.08.2011”

For more information click here >>

Patients’ Stories

This is a letter written by a young American woman, residing in France.The local health system failed to provide her with a medical solution to her problem so she researched her options and contacted iMER urgently. She had been suffering from excruciating knee pain which led to repeated dislocations of the patella, eventually leaving her unable to walk without assistance. Four days after her initial contact with an iMER case manager she knew that her decision was correct and embarked on her journey to Hadassah
Read More >>